Phase
Condition
Bladder Cancer
Urothelial Carcinoma
Urothelial Cancer
Treatment
Contrast Enhanced Ultrasound (CEUS)
Clinical Study ID
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
(a) eligible patients should be 18-year-old or older;
(b) patients should have a histologically or cytologically confirmed diagnosis ofprimary bladder cancer;
(c) patients should not have had any surgery, chemotherapy, immunotherapy, or anytherapy before CEUS diagnosis.
Exclusion
Exclusion Criteria:
(a) participants with confirmed to have no carcinoma of the bladder;
(b) participants with previous pelvic surgery, who had undergone therapy, anybladder surgery, or had received chemotherapy, radiotherapy or immunotherapy;
(c) participants diagnosed with tumor recurrence or metastasis; (d) participants whowere allergic to ultrasound contrast agents or could not tolerate CEUS examination,for instance, with recent myocardial infarction, angina pectoris, cardiacinsufficiency, severe cardiac arrhythmia, a right/left cardiac shunt, severepulmonary hypertension, uncontrolled systemic hypertension, acute respiratorydistress syndrome, or chronic obstructive pulmonary disease.
Study Design
Connect with a study center
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong 510120
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.